Childhood Opportunity and Acute Interstage Outcomes: A National Pediatric Cardiology Quality Improvement

Benjamin Zielonka1, Emily M Bucholz2, Minmin Lu1

  • 1Department of Cardiology, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, MA (B.Z., M.L., L.A.S., D.W.B.).

Circulation
|July 15, 2024
PubMed

Insights

Childhood opportunity did not impact acute interstage outcomes after stage 1 palliation. Home monitoring programs may be mitigating disparities in this high-risk period for infants with congenital heart disease.

Area of Science:

  • Pediatric Cardiology
  • Health Outcomes Research
  • Social Determinants of Health

Background:

  • The interstage period following stage 1 palliation for congenital heart disease is associated with significant morbidity and mortality.
  • The influence of social determinants of health, such as childhood opportunity, on these interstage outcomes is not well understood.

Purpose of the Study:

  • To assess the relationship between childhood opportunity and acute interstage outcomes in infants undergoing stage 1 palliation.
  • To investigate if the Childhood Opportunity Index (COI) is associated with adverse events during the interstage period.

Main Methods:

  • Retrospective review of infants from the National Pediatric Quality Improvement Collaborative Phase II registry (2016-2022) discharged after stage 1 palliation.
  • Utilized zip code-level Childhood Opportunity Index (COI) to categorize patients into 5 levels.
  • Assessed acute interstage outcomes including death, transplant listing, readmission, ICU admission, catheterization, and reoperation using logistic regression.

Main Results:

  • The study included 1837 patients; higher COI levels were associated with increased birth weight and proximity to surgical centers, shorter stage 1 length of stay, and higher rates of exclusive oral feeding at discharge.
  • Over 98% of patients were enrolled in home monitoring across all COI levels.
  • No significant differences in the incidence or timing of acute interstage outcomes were observed across different COI levels, even after adjusting for confounders.

Conclusions:

  • Childhood opportunity, as measured by COI, is linked to variations in preoperative risk factors and hospitalization characteristics for stage 1 palliation.
  • Despite common occurrence, acute interstage outcomes were not associated with COI levels in this cohort, likely due to widespread home monitoring.
  • Further research is warranted to explore the role of home monitoring in mitigating potential disparities during the interstage period.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
1.3K